AR057643A1 - LACOSAMIDE FOR ATTACHED THERAPY - Google Patents
LACOSAMIDE FOR ATTACHED THERAPYInfo
- Publication number
- AR057643A1 AR057643A1 ARP060100304A ARP060100304A AR057643A1 AR 057643 A1 AR057643 A1 AR 057643A1 AR P060100304 A ARP060100304 A AR P060100304A AR P060100304 A ARP060100304 A AR P060100304A AR 057643 A1 AR057643 A1 AR 057643A1
- Authority
- AR
- Argentina
- Prior art keywords
- lacosamide
- therapy
- attached
- attached therapy
- antipsychotics
- Prior art date
Links
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- VPPJLAIAVCUEMN-GFCCVEGCSA-N lacosamide Chemical compound COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1 VPPJLAIAVCUEMN-GFCCVEGCSA-N 0.000 title 1
- 229960002623 lacosamide Drugs 0.000 title 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 230000000561 anti-psychotic effect Effects 0.000 abstract 1
- 239000000164 antipsychotic agent Substances 0.000 abstract 1
- 229940005529 antipsychotics Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
Uso de una clase de compuestos péptidos para la prevencion, alivio y/o tratamiento de una enfermedad tratada con antipsicoticos, en particular psicosis, más particularmente, esquizofrenia, en una terapia adjunta a al menos un antipsicotico.Use of a class of peptide compounds for the prevention, relief and / or treatment of a disease treated with antipsychotics, in particular psychosis, more particularly, schizophrenia, in a therapy attached to at least one antipsychotic.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64741005P | 2005-01-28 | 2005-01-28 | |
| EP05001843A EP1688137A1 (en) | 2005-01-28 | 2005-01-28 | SPM 927 for add-on therapy of schizophrenia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057643A1 true AR057643A1 (en) | 2007-12-12 |
Family
ID=36636204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060100304A AR057643A1 (en) | 2005-01-28 | 2006-01-27 | LACOSAMIDE FOR ATTACHED THERAPY |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1841417A2 (en) |
| JP (1) | JP2008528532A (en) |
| KR (1) | KR20070096058A (en) |
| AR (1) | AR057643A1 (en) |
| AU (1) | AU2006208630B2 (en) |
| BR (1) | BRPI0607043A2 (en) |
| CA (1) | CA2595330A1 (en) |
| EA (1) | EA015566B1 (en) |
| IL (1) | IL183973A0 (en) |
| MX (1) | MX2007009070A (en) |
| NO (1) | NO20074361L (en) |
| WO (1) | WO2006079547A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007144195A2 (en) | 2006-06-15 | 2007-12-21 | Schwarz Pharma Ag | Pharmaceutical composition with synergistic anticonvulsant effect |
| EP1920780A1 (en) * | 2006-10-12 | 2008-05-14 | Schwarz Pharma Ag | Peptide compounds for the treatment of hyperexcitability disorders |
| CN101466390B (en) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | Peptide compounds for the treatment of refractory status epilepticus |
| EP1873527A1 (en) | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
| US20100260716A1 (en) | 2007-10-23 | 2010-10-14 | Ucb Pharma Gmbh | Compounds for treating demyelination conditions |
| US20100151021A1 (en) * | 2008-12-16 | 2010-06-17 | Venkatesh Gopi M | Compositions Comprising Melperone |
| WO2012084126A2 (en) | 2010-12-02 | 2012-06-28 | Ucb Pharma Gmbh | Formulation of lacosamide |
| EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
| CN110087641B (en) | 2016-12-20 | 2024-03-12 | 罗曼治疗系统股份公司 | Transdermal therapeutic systems containing asenapine and polysiloxane or polyisobutylene |
| KR102506333B1 (en) | 2016-12-20 | 2023-03-06 | 에르테에스 로만 테라피-시스테메 아게 | Transdermal absorption treatment system containing asenapine |
| EP3644973B1 (en) | 2017-06-26 | 2021-03-24 | LTS LOHMANN Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
| CN118593482A (en) | 2017-12-05 | 2024-09-06 | 赛诺维信制药公司 | Non-racemic mixture and its use |
| KR20200110317A (en) | 2017-12-05 | 2020-09-23 | 선오비온 파마슈티컬스 인코포레이티드 | Crystal form and method for preparing the same |
| CN112533593A (en) | 2018-06-20 | 2021-03-19 | 罗曼治疗系统股份公司 | Transdermal therapeutic system comprising asenapine |
| CN112704672A (en) | 2018-06-20 | 2021-04-27 | 罗曼治疗系统股份公司 | Transdermal therapeutic system comprising asenapine |
| AU2020286441A1 (en) | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| US11278634B1 (en) | 2021-02-12 | 2022-03-22 | Extrovis Ag | Stable parenteral composition of lacosamide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
| US5773475A (en) * | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
| PT1243262E (en) | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | NEW USE OF A CLASS OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF NON-NEUROPATHIC INFLAMMATORY PAIN |
| DE60100055T2 (en) | 2001-03-21 | 2003-07-24 | Schwarz Pharma Ag | New use of a class of peptide compounds for the treatment of allodynia or other types of chronic or phantom pain |
-
2006
- 2006-01-27 MX MX2007009070A patent/MX2007009070A/en active IP Right Grant
- 2006-01-27 AR ARP060100304A patent/AR057643A1/en not_active Application Discontinuation
- 2006-01-27 CA CA002595330A patent/CA2595330A1/en not_active Abandoned
- 2006-01-27 WO PCT/EP2006/000722 patent/WO2006079547A2/en not_active Ceased
- 2006-01-27 JP JP2007552583A patent/JP2008528532A/en not_active Withdrawn
- 2006-01-27 BR BRPI0607043-4A patent/BRPI0607043A2/en not_active IP Right Cessation
- 2006-01-27 EA EA200701594A patent/EA015566B1/en not_active IP Right Cessation
- 2006-01-27 KR KR1020077019581A patent/KR20070096058A/en not_active Withdrawn
- 2006-01-27 AU AU2006208630A patent/AU2006208630B2/en not_active Ceased
- 2006-01-27 EP EP06706448A patent/EP1841417A2/en not_active Withdrawn
-
2007
- 2007-06-14 IL IL183973A patent/IL183973A0/en unknown
- 2007-08-27 NO NO20074361A patent/NO20074361L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EA015566B1 (en) | 2011-10-31 |
| JP2008528532A (en) | 2008-07-31 |
| KR20070096058A (en) | 2007-10-01 |
| NO20074361L (en) | 2007-10-26 |
| CA2595330A1 (en) | 2006-08-03 |
| EP1841417A2 (en) | 2007-10-10 |
| AU2006208630A1 (en) | 2006-08-03 |
| EA200701594A1 (en) | 2008-02-28 |
| MX2007009070A (en) | 2007-09-12 |
| BRPI0607043A2 (en) | 2009-08-04 |
| AU2006208630B2 (en) | 2011-09-29 |
| WO2006079547A2 (en) | 2006-08-03 |
| IL183973A0 (en) | 2008-12-29 |
| WO2006079547A3 (en) | 2006-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR057643A1 (en) | LACOSAMIDE FOR ATTACHED THERAPY | |
| CY1122522T1 (en) | META ARSENICODE SODIUM FOR USE IN THE MANAGEMENT OF MULTIPLE MYELOMA | |
| NL300936I2 (en) | Semaglutide | |
| CL2007002384A1 (en) | Use of compounds derived from 2,5-dihydroxybenzene for the treatment of psoriasis. | |
| CL2008001234A1 (en) | COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES, INHIBITORS OF APOPTOSIS PROTEINS; AND USE IN THE TREATMENT OF CANCER. | |
| CL2008001076A1 (en) | COMPOUNDS DERIVED FROM SULFONAMIDE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER. | |
| NO20053051D0 (en) | Fatigue reducing agent. | |
| PA8637201A1 (en) | DIFENYLIMIDAZOPIRIMIDINE E-IMIDAZOL AMINAS AS INHIBITORS OF B-SECRETASE | |
| CL2009001099A1 (en) | Use of a human interleukin-2 mutein for the treatment and / or prevention of an autoimmune disease. | |
| AR061446A1 (en) | USE OF 1,7-DIMETHYLXANTINE FOR THE MANUFACTURE OF A NON-ANIOIOUS PSYCHOANALEPTIC DRUG FOR THE TREATMENT OF A NEUROPSYCHIATRIC DISORDER | |
| ATE481984T1 (en) | VACCINE-PEPTIDE COMBINATIONS AGAINST CAT ALLERGY | |
| BRPI0719345A2 (en) | REPLACED DI-HYDROIMIDAZOLS AND ITS USE IN TREATMENT TREATMENT. | |
| CL2007002380A1 (en) | Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis. | |
| FR2864552B1 (en) | SURFACE TREATMENT WITH HYDROXYSULFATE | |
| WO2008028963A3 (en) | Calreticulin for its use as a medication for the treatment of cancer in a mammal | |
| UY28344A1 (en) | NEW COMPOUNDS | |
| AR058173A1 (en) | USE OF SDF-1 FOR THE TREATMENT AND / OR PREVENTION OF NEUROLOGICAL DISEASES | |
| CL2008000865A1 (en) | COMPOUNDS DERIVED FROM BENZIMIDAZOL-2-ONA; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A PSYCHOTIC DISORDER OR A COGNITIVE DETERIORATION. | |
| TW200637538A (en) | Lacosamide for add-on-therapy | |
| UY29417A1 (en) | ENDOPARASITICID AGENTS | |
| DE10394003D2 (en) | Textile treatment agents | |
| DK1838716T3 (en) | Olanzapinpamota dihydrate | |
| ATE404725T1 (en) | TEXTILE TREATMENT | |
| RU2005119153A (en) | MEANS OF TREATMENT OF ACUTE RADIATING DISEASE | |
| ITTV20050186A1 (en) | BED FOR BODY TANNING. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |